l carnitine and tma γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO Frontiers | Gut Microbiota-Dependent Marker

Frontiers Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target JCI The contributory role of gut microbiota in cardiovascular disease Dietary allicin reduces transformation of L carnitine to TMAO through impact on gut microbiota ScienceDirect Revisiting the Role of Carnitine in Heart Disease Through the Lens of the Gut Microbiota PMC Gut microbiota metabolism of l carnitine and cardiovascular risk ScienceDirect Mammalian Microbial Cometabolism of L Carnitine in the Context of Atherosclerosis ScienceDirect

SKU: 60061207640 · From ristorantepizzerianarnali.it